Hereditary amyloidosis: Evidence against early amyloid deposition
Open Access
- 1 November 1989
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 32 (11) , 1474-1476
- https://doi.org/10.1002/anr.1780321119
Abstract
Twelve members of the Indiana hereditary amyloidosis type II kindred were tested for the presence of amyloid deposits. All were young adults (age 26–37), with no evidence of disease and with 1 affected parent. Six were found to be carriers of the variant gene, by DNA testing and/or reduced serum retinol-binding protein levels. Nevertheless, no amyloid could be found in any skin, rectal, or carpal tunnel biopsy specimens. Our results suggest that hereditary amyloidosis type II is a true late-onset disease, in which accumulation of amyloid does not start until late in life—perhaps only a short time before symptoms appear.This publication has 8 references indexed in Scilit:
- A DNA TEST FOR INDIANA SWISS HEREDITARY AMYLOIDOSIS (FAP-II)1988
- The effects of storage of blood and isolated DNA on the integrity of DNAAmerican Journal of Medical Genetics, 1987
- Genetic expression of a transthyretin mutation in typical and late‐onset Portuguese families with familial amyloidotic polyneuropathyNeurology, 1986
- Characterization of a transthyretin (prealbumin) variant associated with familial amyloidotic polyneuropathy type II (Indiana/Swiss).Journal of Clinical Investigation, 1986
- Biochemical and molecular genetic characterization of a new variant prealbumin associated with hereditary amyloidosis.Journal of Clinical Investigation, 1986
- Prealbumin and retinol binding protein serum concentrations in the indiana type hereditary amyloidosisArthritis & Rheumatism, 1983
- PRIMARY SYSTEMIC AMYLOIDOSISMedicine, 1956
- Ocular Manifestations of Hereditary Primary Systemic AmyloidosisArchives of Ophthalmology (1950), 1955